{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:48:45Z","timestamp":1767134925098,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd006496","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T00:00:00Z","timestamp":1216166400000}}],"reference-count":63,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006496.pub2","type":"journal-article","created":{"date-parts":[[2008,6,30]],"date-time":"2008-06-30T07:24:52Z","timestamp":1214810692000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adjunctive therapies for AIDS dementia complex"],"prefix":"10.1002","volume":"2010","author":[{"given":"Olalekan A","family":"Uthman","sequence":"first","affiliation":[{"name":"Save the Youth Initiative; P. O. Box 5146 Ilorin Kwara State Nigeria 240-001"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jubril O","family":"Abdulmalik","sequence":"additional","affiliation":[{"name":"Federal Neuropsychiatric Hospital; Maiduguri Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,16]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD006496.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000034177.47015.DA","article-title":"A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment","volume":"59","author":"Clifford","year":"2002","journal-title":"Neurology"},{"issue":"10","key":"10.1002\/14651858.CD006496.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000034177.47015.DA","article-title":"A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment","volume":"59","author":"Clifford","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD006496.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.50.3.645","article-title":"A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders","volume":"50","year":"1998","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD006496.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.50.3.645","article-title":"A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders","volume":"50","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD006496.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.49.1.142","article-title":"Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders","volume":"49","year":"1997","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD006496.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.50.3.645","article-title":"A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders","volume":"50","year":"1998","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD006496.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/13550280600827344","article-title":"Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment","volume":"12","author":"Goodkin","year":"2006","journal-title":"Journal of Neurovirology"},{"issue":"1","key":"10.1002\/14651858.CD006496.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archneur.55.1.41","article-title":"Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment","volume":"55","author":"Heseltine","year":"1998","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD006496.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1212\/WNL.51.1.221","article-title":"A phase I\/II trial of nimodipine for HIV-related neurologic complications","volume":"51","author":"Navia","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD006496.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1212\/WNL.51.1.221","article-title":"A phase I\/II trial of nimodipine for HIV-related neurologic complications","volume":"51","author":"Navia","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD006496.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1212\/WNL.54.1.233","article-title":"Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study","volume":"54","author":"Sacktor","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD006496.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1212\/WNL.53.2.391","article-title":"Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium","volume":"53","author":"Schifitto","year":"1999","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD006496.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.wnl.0000204294.28189.03","article-title":"Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report","volume":"66","author":"Schifitto","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD006496.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/QAD.0b013e32813384e8","article-title":"Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study","volume":"21","author":"Schifitto","year":"2007","journal-title":"AIDS"},{"issue":"13","key":"10.1002\/14651858.CD006496.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/01.wnl.0000268487.78753.0f","article-title":"A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment","volume":"69","author":"Schifitto","year":"2007","journal-title":"Neurology"},{"issue":"13","key":"10.1002\/14651858.CD006496.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/01.wnl.0000268487.78753.0f","article-title":"A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment","volume":"69","author":"Schifitto","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD006496.pub2-BIB0017|cit17","first-page":"52","article-title":"Analyses of peptide T efficacy on neuropsychological performance","volume":"10","year":"1996","journal-title":"AIDS Patient Care STDS"},{"issue":"3","key":"10.1002\/14651858.CD006496.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1371\/journal.pctr.0020013","article-title":"Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial","volume":"2","author":"Brew","year":"2007","journal-title":"PLoS Clinical Trials"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(89)90416-9","article-title":"Improvement in AIDS patients on peptide T","volume":"2","author":"Bridge","year":"1989","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0020|cit20","first-page":"237","article-title":"Results of extended peptide T administration in AIDS and ARC patients","volume":"27","author":"Bridge","year":"1991","journal-title":"Psychopharmacology bulletin"},{"issue":"4","key":"10.1002\/14651858.CD006496.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.neuroimage.2004.07.067","article-title":"A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age","volume":"23","author":"Chang","year":"2004","journal-title":"NeuroImage"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2377-6-42","article-title":"Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study","volume":"6","author":"Cysique","year":"2006","journal-title":"BMC neurology"},{"issue":"1","key":"10.1002\/14651858.CD006496.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1176\/jnp.4.1.15","article-title":"Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort","volume":"4","author":"Day","year":"1992","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"11","key":"10.1002\/14651858.CD006496.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1128\/AAC.48.11.4328-4331.2004","article-title":"Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults","volume":"48","author":"DiCenzo","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0025|cit25","first-page":"1520","article-title":"Nimodipine plus zidovudine versus zidovudine alone in the treatment of HIV-1-associated cognitive deficits","volume":"11","author":"Galgani","year":"1997","journal-title":"AIDS"},{"issue":"4","key":"10.1002\/14651858.CD006496.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/00952999709016894","article-title":"Treatment of early AIDS dementia in intravenous drug users: high versus low dose peptide T","volume":"23","author":"Kosten","year":"1997","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"6","key":"10.1002\/14651858.CD006496.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jmri.10295","article-title":"A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis","volume":"17","author":"Lee","year":"2003","journal-title":"Journal of Magnetic Resonance Imaging"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0196-9781(03)00176-1","article-title":"Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA)","volume":"24","author":"Polianova","year":"2003","journal-title":"Peptides"},{"issue":"2","key":"10.1002\/14651858.CD006496.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/13550280290049615","article-title":"HIV-associated cognitive impairment before and after the advent of combination therapy","volume":"8","author":"Sacktor","year":"2002","journal-title":"Journal of Neurovirology"},{"issue":"3","key":"10.1002\/14651858.CD006496.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1212\/WNL.56.3.415","article-title":"Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes","volume":"56","author":"Schifitto","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD006496.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/13550280600873835","article-title":"A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy","volume":"12","author":"Schifitto","year":"2006","journal-title":"Journal of Neurovirology"},{"issue":"24","key":"10.1002\/14651858.CD006496.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM198812153192404","article-title":"Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex","volume":"319","author":"Schmitt","year":"1988","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006496.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410330403","article-title":"Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group","volume":"33","author":"Sidtis","year":"1993","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD006496.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/WNL.47.5.1254","article-title":"Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group","volume":"47","author":"Simpson","year":"1996","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD006496.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00002030-199305000-00012","article-title":"Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex","volume":"7","author":"Tozzi","year":"1993","journal-title":"AIDS"},{"issue":"7","key":"10.1002\/14651858.CD006496.pub2-BIB0036|cit36","first-page":"1177","article-title":"Peptide T and glucose metabolism in AIDS dementia complex","volume":"37","author":"Villemagne","year":"1996","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0037|cit37","unstructured":"Vitiello B Research on possible treatments of HIV-associated cognitive impairment The XII International AIDS Conference; 1998 June 28 - July 3; Geneva, Switzerland 1998 1148 (abstract no. 60804)"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0038|cit38","unstructured":"Minocycline for the Treatment of Decreased Mental Function in HIV Infected Adults www.clinicaltrials.gov\/ct\/show\/NCT00361257?order=1"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0039|cit39","unstructured":"Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1 www.clinicaltrials.gov\/ct\/show\/NCT00000738?order=1"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0040|cit40","unstructured":"AIDS institutes Cognitive disorders and HIV\/AIDS: HIV - associated dementia and delirium www.hivguidelines.org\/GuideLine.aspx?pageID=261&guideLineID=44&vType=txt"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/13550280500511790","article-title":"Human immunodeficiency virus dementia patients in Africa: How many? Who cares? And where to from here?","volume":"11 Suppl 3","author":"Birbeck","year":"2005","journal-title":"Journal of Neurovirolology"},{"issue":"1","key":"10.1002\/14651858.CD006496.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00042560-199601010-00005","article-title":"Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group","volume":"11","author":"Chiesi","year":"1996","journal-title":"Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology"},{"issue":"3","key":"10.1002\/14651858.CD006496.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.52.3.607","article-title":"Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy","volume":"52","author":"Childs","year":"1999","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD006496.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.47.5.1247","article-title":"Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive\/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders","volume":"47","year":"1996","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0045|cit45","doi-asserted-by":"crossref","unstructured":"Edward DD Competition' cause of AIDS dementia? Science News Sept 1987 www.findarticles.com\/p\/articles\/mi_m1200\/is_v132\/ai_5197123","DOI":"10.2307\/3971941"},{"issue":"7109","key":"10.1002\/14651858.CD006496.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-4690-3-28","article-title":"HIV-1 associated dementia: symptoms and causes","volume":"3","author":"Ghafouri","year":"2006","journal-title":"Retrovirology"},{"issue":"1","key":"10.1002\/14651858.CD006496.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS","volume":"5","author":"Gonzalez-Scarano","year":"2005","journal-title":"Nature Reviews Immunology"},{"issue":"7414","key":"10.1002\/14651858.CD006496.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0050|cit50","unstructured":"Higgins JPT Green S Analysis and presenting results. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 8 www.cochrane.org\/resources\/handbook\/hbook.htm"},{"issue":"7303","key":"10.1002\/14651858.CD006496.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"British Medical Journal"},{"issue":"9","key":"10.1002\/14651858.CD006496.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1474-4422(05)70165-4","article-title":"Neurological complications of HIV infection","volume":"4","author":"McArthur","year":"2005","journal-title":"Lancet Neurology"},{"issue":"9193","key":"10.1002\/14651858.CD006496.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD006496.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0166-2236(00)01819-1","article-title":"Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants","volume":"24","author":"Mollace","year":"2001","journal-title":"Trends in Neuroscience"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0055|cit55","unstructured":"Parnes RB AIDS Dementia Complex www.thirdage.com\/healthgate\/files\/43788.html"},{"issue":"9025","key":"10.1002\/14651858.CD006496.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(95)11035-6","article-title":"Neurological complications of HIV infection","volume":"348","author":"Price","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0057|cit57","unstructured":"Ramsay C How do you include trials with more than two groups into a single meta-analysis? www.epoc.uottawa.ca\/FAQmultiplegroups2003.pdf"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0058|cit58","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2003"},{"issue":"2","key":"10.1002\/14651858.CD006496.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/13550289709015799","article-title":"Prospects for therapy of HIV-associated neurologic diseases","volume":"3","author":"Sacktor","year":"1997","journal-title":"Journal of Neurovirology"},{"issue":"2","key":"10.1002\/14651858.CD006496.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2466\/pms.1991.73.2.539","article-title":"Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort Study","volume":"73","author":"Selnes","year":"1991","journal-title":"Perceptual and Motor Skills"},{"issue":"3","key":"10.1002\/14651858.CD006496.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archneur.58.3.473","article-title":"Factors associated with incident human immunodeficiency virus-dementia","volume":"58","author":"Stern","year":"2001","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD006496.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/1570162033485113","article-title":"Neuroprotective therapy for HIV dementia","volume":"1","author":"Turchan","year":"2003","journal-title":"Current HIV Research"},{"issue":"16","key":"10.1002\/14651858.CD006496.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.293.16.2003","article-title":"Neuroprotective and anti-human immunodeficiency virus activity of minocycline","volume":"293","author":"Zink","year":"2005","journal-title":"Journal of the American Medical Association"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006496.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:49:30Z","timestamp":1751366970000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006496.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane HIV\/AIDS Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,7,16]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006496.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,16]]}}}